What happened
President Joe Biden and Vice President Kamala Harris appeared together Thursday to celebrate Medicare's first successful price negotiation with drugmakers, as allowed under Biden's 2022 Inflation Reduction Act (IRA). Medicare will pay 38% to 79% below list price for 10 top-selling drugs when the newly negotiated prices take effect in 2026, saving taxpayers a projected $6 billion a year and Medicare beneficiaries $1.5 billion.
Who said what
The first joint appearance by Biden and Harris since the president dropped out of the race was "billed as an official White House policy event," but it "quickly took on the tone and feel of a campaign rally," The Washington Post said. "We finally beat Big Pharma," Biden told the crowd in Largo, Maryland, and "with not one Republican vote in the entire Congress." He called Harris, who provided the tie-breaking Senate vote for the IRA, an "incredible partner in the progress we've made," adding, "she's going to make one hell of a president."
Donald Trump, in a meandering press conference shortly afterward, called the IRA a "con job" and said he was "entitled to personal attacks" on Harris. "I don't have a lot of respect for her intelligence, and I think she'll be a terrible president," he said.
What next?
Medicare plans to negotiate lower prices on 15 more drugs in 2025 and 2026, and 20 drugs in the following years. It's not clear how much the price reductions will help individual beneficiaries, but the IRA's $2,000-a-year cap on personal drug spending and $35 monthly ceiling on insulin costs take effect for Medicare patients next year.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
Homes by renowned architectsFeature Featuring a Leonard Willeke Tudor Revival in Detroit and modern John Storyk design in Woodstock
-
Looming drone ban has farmers and farm-state Republicans anxiousIN THE SPOTLIGHT As congressional China-hawks work to limit commercial drone sales from Beijing, a growing number of conservative lawmakers are sounding an agricultural alarm
-
Mind-expanding podcasts you may have missed this fallThe Week Recommends True crime, a book club and a therapeutic outlet led this season’s best podcasts
-
Are Republicans going to do a deal on health care?Today's Big Question Obamacare subsidies are expiring soon
-
Trump’s Ukraine peace talks advance amid leaked callSpeed Read Trump’s envoy Steve Witkoff is set to visit Russia next week
-
Memo signals Trump review of 233k refugeesSpeed Read The memo also ordered all green card applications for the refugees to be halted
-
Pentagon targets Kelly over ‘illegal orders’ videoSpeed Read The Pentagon threatened to recall Kelly to active duty
-
Judge tosses Trump DOJ cases against Comey, JamesSpeed Read Both cases could potentially be brought again
-
US, Kyiv report progress on shifting Ukraine peace planSpeed Read The deal ‘must fully uphold Ukraine’s sovereignty,’ the countries said
-
Comey grand jury never saw final indictmentSpeed Read This ‘drove home just how slapdash’ the case is, said The New York Times
-
Summers out at Harvard, OpenAI amid Epstein furorSpeed Read Summers was part of a group being investigated by Harvard for Epstein ties
